Cancer treatment has evolved from traditional chemotherapy and radiotherapy to more targeted approaches. Targeted therapies, such as tyrosine kinase inhibitors, focus on specific molecular targets. Immunotherapy, including checkpoint inhibitors and CAR-T cell therapy, harnesses the body's immune system to fight cancer. Additionally, personalized medicine tailors treatment based on the genetic profile of the patient’s tumor.
